Jinxin Fertility Group Limited (abbreviation: JXR) filed a Next Day Disclosure Return after repurchasing 1.33 million ordinary shares on 7 October 2026. The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK $2.21 to HK $2.29, implying a volume-weighted average cost of roughly HK $2.26 per share and a total consideration of HK $3.01 million.

Following the transaction: • Issued shares (excluding treasury shares) fell to 2.67 billion, a decline of 0.05%. • Treasury shares increased to 35.58 million. • Total issued share capital remained unchanged at 2.71 billion shares.

The buy-back was executed under the mandate granted on 25 June 2026, which authorises the repurchase of up to 262.51 million shares. Cumulative purchases under this mandate now stand at 48.13 million shares, equivalent to 1.83% of the share count on the mandate date.

In addition, 92.47 million shares bought between 27 March and 25 August 2026 are designated for cancellation but had not yet been cancelled as of 7 October 2026.

Under Listing Rule 10.06(3)(a), JXR is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, lasting until 6 November 2026.